The PTX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the PTX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The PTX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View PTX Detailed Price Forecast - CNN Money||View PTX Detailed Summary - Google Finance|
|View PTX Detailed Summary - Yahoo! Finance||View PTX Stock Research & Analysis - Zacks.com|
|View PTX Trends & Analysis - Trade-Ideas||View PTX Major Holders - Barrons|
|View PTX Call Transcripts - NASDAQ||View PTX Breaking News & Analysis - Seeking Alpha|
|View PTX Annual Report - CompanySpotlight.com||View PTX OTC Short Report - OTCShortReport.com|
|View PTX Fundamentals - TradeKing||View PTX SEC Filings - Bar Chart|
|View Historical Prices for PTX - The WSJ||View Performance/Total Return for PTX - Morningstar|
|View the Analyst Estimates for PTX - MarketWatch||View the Earnings History for PTX - CNBC|
|View the PTX Earnings - StockMarketWatch||View PTX Buy or Sell Recommendations - MacroAxis|
|View the PTX Bullish Patterns - American Bulls||View PTX Short Pain Metrics - ShortPainBot.com|
|View PTX Stock Mentions - StockTwits||View PTX Stock Mentions - PennyStockTweets|
|View PTX Stock Mentions - Twitter||View PTX Investment Forum News - Investor Hub|
|View PTX Stock Mentions - Yahoo! Message Board||View PTX Stock Mentions - Seeking Alpha|
|View Insider Transactions for PTX - SECform4.com||View Insider Transactions for PTX - Insider Cow|
|View PTX Major Holdings Summary - CNBC||View Insider Disclosure for PTX - OTC Markets|
|View Insider Transactions for PTX - Yahoo! Finance||View Institutional Holdings for PTX - NASDAQ|
|View PTX Stock Insight & Charts - FinViz.com||View PTX Investment Charts - StockCharts.com|
|View PTX Stock Overview & Charts - BarChart||View PTX User Generated Charts - Trading View|
Pernix Therapeutics Holdings, Inc.’s Subsidiaries File Notice of Appeal in Patent Litigation Concerning Zohydro® ER with BeadTek®
Posted on Wednesday September 12, 2018
Pernix Therapeutics Holdings, Inc. (PTX), announced today that, on September 7, 2018, its subsidiaries, Pernix Therapeutics, LLC, a specialty pharmaceutical company, and Pernix Ireland Pain Designated Activity Company, filed a notice of appeal to the United States Court of Appeals for the Federal Circuit in the Company’s litigation against Alvogen Malta Operations, Ltd. (Alvogen). The litigation relates to Alvogen’s submission of an Abbreviated New Drug Application (ANDA) to the U.S. Food & Drug Administration (FDA) seeking approval to market a generic version of Pernix’s Zohydro® ER with BeadTek® (hydrocodone bitartrate). The United States District Court for the District of Delaware previously found the asserted claims of U.S. Patent Nos.
Edited Transcript of PTX earnings conference call or presentation 9-Aug-18 8:30pm GMT
Posted on Tuesday September 11, 2018
Q2 2018 Pernix Therapeutics Holdings Inc Earnings Call
Pernix Therapeutics Announces Ruling in Patent Litigation Concerning Zohydro® ER with BeadTek®
Posted on Monday August 27, 2018
Pernix Therapeutics Holdings, Inc. (PTX), a specialty pharmaceutical company, announced today that in the Company’s litigation against Alvogen Malta Operations, Ltd. (Alvogen), the United States District Court for the District of Delaware found the asserted claims of U.S. Patent Nos. 9,265,760 and 9,339,499, which relate to methods of treating patients with mild and moderate hepatic impairment with hydrocodone bitartrate, to be infringed, but invalid. The litigation relates to Alvogen’s submission of an Abbreviated New Drug Application (ANDA) to the U.S. Food & Drug Administration (FDA) seeking approval to market a generic version of Pernix’s Zohydro® ER with BeadTek® (hydrocodone bitartrate).
Pernix Therapeutics Reports Second Quarter 2018 Financial Results
Posted on Thursday August 09, 2018
MORRISTOWN, N.J., Aug. 09, 2018--. Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, announced today its financial results for the three and six months ended June 30, 2018.. Second ...